[go: up one dir, main page]

WO1996025183A3 - Compositions ophtalmiques renfermant des peptides et des derives peptidiques et procedes d'utilisation - Google Patents

Compositions ophtalmiques renfermant des peptides et des derives peptidiques et procedes d'utilisation Download PDF

Info

Publication number
WO1996025183A3
WO1996025183A3 PCT/US1996/001728 US9601728W WO9625183A3 WO 1996025183 A3 WO1996025183 A3 WO 1996025183A3 US 9601728 W US9601728 W US 9601728W WO 9625183 A3 WO9625183 A3 WO 9625183A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
same
ophthalmic compositions
compositions including
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1996/001728
Other languages
English (en)
Other versions
WO1996025183A2 (fr
Inventor
Stanley W Huth
James P Currie
John C Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Priority to AU48657/96A priority Critical patent/AU4865796A/en
Publication of WO1996025183A2 publication Critical patent/WO1996025183A2/fr
Publication of WO1996025183A3 publication Critical patent/WO1996025183A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

L'invention concerne des compositions ophtalmiques et des procédés pour les conserver et les utiliser. Dans un mode de réalisation, lesdites compositions renferment un milieu liquide, un premier constituant antimicrobien choisi parmi des peptides antimicrobiens et des mélanges de ceux-ci et un second constituant antimicrobien différent du premier, de préférence pratiquement non oxydant. L'invention concerne également des compositions renfermant un milieu liquide et des nanotubes de peptides antimicrobiens efficaces pour désinfecter une lentille de contact placée dans le milieu liquide contenant lesdits nanotubes. Le champ d'application de la présente invention couvre des compositions avec agents conservateurs efficaces pour le soin des lentilles de contact.
PCT/US1996/001728 1995-02-17 1996-02-08 Compositions ophtalmiques renfermant des peptides et des derives peptidiques et procedes d'utilisation Ceased WO1996025183A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48657/96A AU4865796A (en) 1995-02-17 1996-02-08 Ophthalmic compositions including peptides and peptide derivatives and methods for using same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39000695A 1995-02-17 1995-02-17
US08/390,006 1995-02-17

Publications (2)

Publication Number Publication Date
WO1996025183A2 WO1996025183A2 (fr) 1996-08-22
WO1996025183A3 true WO1996025183A3 (fr) 1996-10-10

Family

ID=23540656

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/001728 Ceased WO1996025183A2 (fr) 1995-02-17 1996-02-08 Compositions ophtalmiques renfermant des peptides et des derives peptidiques et procedes d'utilisation

Country Status (2)

Country Link
AU (1) AU4865796A (fr)
WO (1) WO1996025183A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482799B1 (en) 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
WO2002064183A1 (fr) * 2001-02-09 2002-08-22 Johnson & Johnson Vision Care, Inc. Dispositif biomedicaux avec des revetements de proteines et de peptides cationiques antimicrobiens
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
US7368127B2 (en) 2002-12-19 2008-05-06 Johnson & Johnson Vision Care, Inc. Biomedical devices with peptide containing coatings
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative
CN101212906B (zh) * 2005-07-01 2011-09-28 凯恩生物科技有限公司 用于在医疗装置上抑制微生物薄膜的生长和增殖的抗微生物组合物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
WO1991007192A1 (fr) * 1989-11-21 1991-05-30 Schering Corporation Systeme de desinfection de lentilles de contact
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
WO1994021672A1 (fr) * 1993-03-19 1994-09-29 The Regents Of The University Of California Nouveaux peptides antimicrobiens issus de neutrophiles bovins
WO1996006532A1 (fr) * 1994-09-01 1996-03-07 Novo Nordisk A/S Composition proteique basique destinee a tuer ou a inhiber des cellules microbiennes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
WO1991007192A1 (fr) * 1989-11-21 1991-05-30 Schering Corporation Systeme de desinfection de lentilles de contact
WO1994021672A1 (fr) * 1993-03-19 1994-09-29 The Regents Of The University Of California Nouveaux peptides antimicrobiens issus de neutrophiles bovins
WO1996006532A1 (fr) * 1994-09-01 1996-03-07 Novo Nordisk A/S Composition proteique basique destinee a tuer ou a inhiber des cellules microbiennes

Also Published As

Publication number Publication date
WO1996025183A2 (fr) 1996-08-22
AU4865796A (en) 1996-09-04

Similar Documents

Publication Publication Date Title
CA2070293A1 (fr) Compositions ophtalmiques et leurs methodes de conservation et d'utilisation
CA2070286A1 (fr) Compositions ophtalmiques non oxydantes et leurs methodes de conservation et d'utilisation
AU3100195A (en) Saline solution for treating contact lenses
CA2309172A1 (fr) Aminobiguanides pour la desinfection des lentilles de contact et la conservation de compositions pharmaceutiques
DK0484281T4 (da) Cyclosporiner
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
AU8011691A (en) Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents
ATE187891T1 (de) Ophtalmische zusammensetzungen enthaltend amidoamine
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
CA2138960A1 (fr) Compositions ophtalmiques et methodes pour les conserver et les utiliser
WO1996025183A3 (fr) Compositions ophtalmiques renfermant des peptides et des derives peptidiques et procedes d'utilisation
NO951989D0 (no) Anvendelse av amidoaminer i öyepreparater
US5549894A (en) Disinfecton formulations and methods using D-enantiomeric anti-microbial peptides
CA2154179A1 (fr) Compositions et methodes de desinfection pour les lentilles corneennes
PT789764E (pt) Nova familia de inibidores de protease e outras substancias biologicas activas
GR3024267T3 (en) Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor.
CA2247862A1 (fr) Traitement de lentilles de contact avec une solution aqueuse contenant des composes phosphoniques
WO1996018406A3 (fr) Formulations ophtalmiques de glycosides substitues

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase